/
/
/

Bliss GVS Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)621.90
Volume (₹)3.09 L
High (₹)655.40
Upper Circuit655.40
Low (₹)601.00
Lower Circuit593.00
Prev Close624.20
52W High (₹)739.90
Price655.40
52W Low (₹)118.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)6596.87 Cr
Div. Yield (%)0.24
PE Ratio40.93
Debt to Equity0.00
Price to Book1.93
Book Value111.66
EPS (TTM)15.15
Face Value1.00
ROE (%)12.11

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
BLISSGVS-BENSE
LTP
1W Low
1W High
Market cap (₹)
1904.5+75.5 (4.13%)
1762.40
1943.90
4,59,497Cr
11565.5+1425 (14.05%)
9888
11824
2,94,146Cr
4780+70 (1.49%)
4679.10
4835
1,81,474Cr
2454+108 (4.60%)
2288.20
2480
1,28,054Cr
1215.9+22.9 (1.92%)
1172
1232.30
1,19,700Cr
1385+19 (1.39%)
1357
1390.30
1,14,349Cr
1403.8-0.3 (-0.02%)
1382
1421.40
1,13,989Cr
2668.3+150.3 (5.97%)
2489
2705
1,06,446Cr
1855.3+70.3 (3.94%)
1696
1856.10
1,03,913Cr
2025+37 (1.86%)
1944.10
2036.50
91,230Cr
655.4+22.95 (3.63%)
585.15
655.40
6,597Cr

Key Highlights of Bliss GVS Pharma Ltd Balance Sheet

Bliss GVS Pharma Ltd balance sheet discloses shareholders' funds of ₹10.58Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹10.58Cr, and the reserves and surplus of the company is ₹1132.95Cr.

The company has its non-current liabilities with total liabilities of ₹1329.08Cr as of 2026-03-31.

The current liabilities are ₹168.59Cr as of 2026-03-31. At the same time, current assets are ₹826.36Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹18.69Cr and tangible assets of ₹419.54Cr, provided in the Bliss GVS Pharma Ltd financial statements.